Clotting factor activity levels and bleeding risk in people with haemophilia playing sports
Haemophilia · 2023
DOI: 10.1111/hae.14800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, 2023. Verfasst von Olav Versloot und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Ne…. Hauptthemen laut MEDLINE: Athletic Injuries, Hemophilia A, Sports. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bayer.
Abstract (Originalsprache)
Background
Improved treatment options for people with haemophilia (PWH) have increased the possibilities for sports participation, but the risk of sports‐induced bleeding (SIB) is still considered considerable by many.
Aim
To assess sports associated injury‐ and bleeding risk in PWH and to assess clotting levels associated with safe sports participation.
Methods
Sports injuries and SIBs were prospectively collected for 12 months in PWH aged 6–49 without inhibitors playing sports at least once weekly. Injuries were compared according to factor levels, severity, joint health, sports risk category and sports intensity. Factor activity at the time of injury was estimated using a pharmacokinetic model.
Results
125 participants aged 6–49 (41 children, 90% haemophilia A; 48% severe, 95% severe on prophylaxis) were included. Sports injuries were reported by 51 participants (41%). Most participants (62%) reported no bleeds at all and only 16% reported SIBs. SIBs were associated with factor levels at time of injury (OR: 0.93/%factor level (CI 0.88–0.99); p = .02), but not with haemophilia severity (OR: 0.62 (CI 0.20–1.89); p = .40), joint health, sports risk category or sports intensity. PWH with factor levels 10%) factor levels.
Conclusion
The results of this study emphasize the importance of clotting factor levels in prevention of bleeds. This information is vital for patient counselling and tailoring prophylactic treatment with clotting factors and non‐replacement therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Department of Physiotherapy, Institute of Movement Studies, University of Applied Science Utrecht, Utrecht, The Netherlands.
- Dutch Consumer Safety Institute, Utrecht, Amsterdam, The Netherlands.
- Center for Child Development, Exercise and Physical Literacy, University Children's Hospital, University Medical Center, Utrecht University, Utrecht, The Netherlands.
- Rehabilitation Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Förderung
- Bayer
Zitieren
APA
Versloot, O., Kemler, E., Blokzijl, J., Timmer, M., Schuuring, M., van Galen, K. P. M., Kremer Hovinga, I. C. L., van der Valk, P. R., van Vulpen, L. F. D., Schutgens, R. E. G., van Koppenhagen, C. F., van der Net, J., & Fischer, K. (2023). Clotting factor activity levels and bleeding risk in people with haemophilia playing sports. Haemophilia. https://doi.org/10.1111/hae.14800
Vancouver
Versloot O, Kemler E, Blokzijl J, Timmer M, Schuuring M, van Galen KPM, et al. Clotting factor activity levels and bleeding risk in people with haemophilia playing sports. Haemophilia. 2023. doi:10.1111/hae.14800
BibTeX
@article{Versloot2023,
author = {Versloot, Olav and Kemler, Ellen and Blokzijl, Johan and Timmer, Merel and Schuuring, Marleen and van Galen, Karin P M and Kremer Hovinga, Idske Cornelia L and van der Valk, Paul R and van Vulpen, Lize F D and Schutgens, Roger E G and van Koppenhagen, Casper F and van der Net, Janjaap and Fischer, Kathelijn},
title = {Clotting factor activity levels and bleeding risk in people with haemophilia playing sports},
journal = {Haemophilia},
year = {2023},
doi = {10.1111/hae.14800}
}
EUVIMED